Credit Suisse Ag Nevro Corp Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Nevro Corp stock. As of the latest transaction made, Credit Suisse Ag holds 412,705 shares of NVRO stock, worth $2.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

412,705

Previous 414,711 0.48%

Holding current value

$2.41 Million

Previous $8.92 Million 33.23%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$13.56 - $20.78 $27,201 - $41,684	-2,006 Reduced 0.48%	412,705 $5.96 Million
Q4 2023 Feb 08, 2024	BUY	$14.18 - $22.31 $60,165 - $94,661	4,243 Added 1.03%	414,711 $8.92 Million
Q3 2023 Nov 13, 2023	SELL	$18.22 - $25.85 $21,335 - $30,270	-1,171 Reduced 0.28%	410,468 $7.89 Million
Q2 2023 Aug 11, 2023	BUY	$22.62 - $39.32 $1.39 Million - $2.42 Million	61,424 Added 17.54%	411,639 $10.5 Million
Q1 2023 May 10, 2023	SELL	$30.17 - $41.11 $5.39 Million - $7.35 Million	-178,717 Reduced 33.79%	350,215 $12.7 Million
Q4 2022 Feb 13, 2023	BUY	$36.43 - $49.4 $325,684 - $441,636	8,940 Added 1.72%	528,932 $20.9 Million
Q3 2022 Nov 10, 2022	SELL	$40.66 - $53.03 $203 - $265	-5 Reduced -0.0%	519,992 $24.2 Million
Q2 2022 Aug 12, 2022	SELL	$40.85 - $77.67 $60,498 - $115,029	-1,481 Reduced 0.28%	519,997 $22.8 Million
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $341,415 - $524,281	5,695 Added 1.1%	521,478 $37.7 Million
Q4 2021 Feb 14, 2022	SELL	$81.07 - $121.29 $673,610 - $1.01 Million	-8,309 Reduced 1.59%	515,783 $41.8 Million
Q3 2021 Nov 12, 2021	BUY	$101.99 - $166.36 $93,218 - $152,053	914 Added 0.17%	524,092 $61 Million
Q2 2021 Aug 16, 2021	SELL	$141.6 - $179.06 $12.1 Million - $15.3 Million	-85,434 Reduced 14.04%	523,178 $86.6 Million
Q1 2021 May 14, 2021	BUY	$132.81 - $182.18 $23.9 Million - $32.8 Million	179,787 Added 41.93%	608,612 $84.9 Million
Q4 2020 Feb 12, 2021	BUY	$138.17 - $184.34 $169,949 - $226,738	1,230 Added 0.29%	428,825 $74.2 Million
Q3 2020 Nov 13, 2020	SELL	$114.09 - $145.51 $1.95 Million - $2.49 Million	-17,121 Reduced 3.85%	427,595 $59.6 Million
Q2 2020 Aug 12, 2020	BUY	$89.45 - $129.85 $10.8 Million - $15.6 Million	120,363 Added 37.11%	444,716 $53.1 Million
Q1 2020 May 13, 2020	BUY	$70.23 - $144.31 $925,631 - $1.9 Million	13,180 Added 4.24%	324,353 $32.4 Million
Q4 2019 Feb 12, 2020	BUY	$76.41 - $117.54 $982,938 - $1.51 Million	12,864 Added 4.31%	311,173 $36.6 Million
Q3 2019 Nov 12, 2019	SELL	$61.52 - $91.1 $15.4 Million - $22.8 Million	-250,036 Reduced 45.6%	298,309 $25.6 Million
Q2 2019 Aug 14, 2019	BUY	$58.04 - $66.99 $104,820 - $120,983	1,806 Added 0.33%	548,345 $35.5 Million
Q1 2019 May 14, 2019	SELL	$35.52 - $62.62 $1.75 Million - $3.08 Million	-49,220 Reduced 8.26%	546,539 $34.2 Million
Q4 2018 Feb 13, 2019	BUY	$35.43 - $56.29 $1.87 Million - $2.97 Million	52,692 Added 9.7%	595,759 $23.2 Million
Q3 2018 Nov 13, 2018	BUY	$44.22 - $75.47 $8.92 Million - $15.2 Million	201,686 Added 59.08%	543,067 $31 Million
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $1.62 Million - $2.07 Million	-22,394 Reduced 6.16%	341,381 $27.3 Million
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $6.65 Million - $8.48 Million	95,799 Added 35.75%	363,775 $31.5 Million
Q4 2017 Feb 14, 2018	BUY	$65.94 - $93.31 $14.6 Million - $20.7 Million	222,047 Added 483.46%	267,976 $18.5 Million
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $2.71 Million - $3.05 Million	33,521 Added 270.16%	45,929 $4.17 Million
Q2 2017 Aug 14, 2017	BUY	N/A	12,408	12,408 $924,000

Others Institutions Holding NVRO

# of Institutions

Shares Held

6.52M

Call Options Held

50K

Put Options Held

150K

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $207M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account